stable hla g knockdown cells (Santa Cruz Biotechnology)
92
Structured Review
Santa Cruz Biotechnology
stable hla g knockdown cells
Stable Hla G Knockdown Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stable+hla+g+knockdown+cells/HLA-G+shRNA+(h)+Lentiviral+Particles/pm41632088-77-2-12
Average 92 stars, based on 5 article reviews
Stable Hla G Knockdown Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stable+hla+g+knockdown+cells/HLA-G+shRNA+(h)+Lentiviral+Particles/pm41632088-77-2-12
Average 92 stars, based on 5 article reviews
stable hla g knockdown cells - by Bioz Stars,
2026-10
92/100 stars
Images
Related Articles
Knockdown:Article Title: CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of TCE‐secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity Article Snippet: To generate CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc, and CD3ε Nb‐CD63‐NLuc‐overexpressing cells, pExo plasmids encoding CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc or CD3ε Nb‐CD63‐NLuc chimeric protein were transfected into HEK‐293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain Article Title: CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE-Secreting CAR-Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity. Article Snippet: CD3 εNb-CD63, CD3 εNb-Mouse CD63, CD63-NLuc, CD3 εNb-CD63-NLuc, HLA-G Knockdown, HLA-G KO, PD-L1 KO, and HLA-G/PD-L1 DKO To generate CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc, and CD3 ε Nb-CD63-NLuc-overexpressing cells, pExo plasmids encoding CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc or CD3 ε Nb-CD63-NLuc chimeric protein were transfected into HEK-293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain shRNA:Article Title: CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of TCE‐secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity Article Snippet: To generate CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc, and CD3ε Nb‐CD63‐NLuc‐overexpressing cells, pExo plasmids encoding CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc or CD3ε Nb‐CD63‐NLuc chimeric protein were transfected into HEK‐293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain Article Title: CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE-Secreting CAR-Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity. Article Snippet: CD3 εNb-CD63, CD3 εNb-Mouse CD63, CD63-NLuc, CD3 εNb-CD63-NLuc, HLA-G Knockdown, HLA-G KO, PD-L1 KO, and HLA-G/PD-L1 DKO To generate CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc, and CD3 ε Nb-CD63-NLuc-overexpressing cells, pExo plasmids encoding CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc or CD3 ε Nb-CD63-NLuc chimeric protein were transfected into HEK-293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain Transfection:Article Title: CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of TCE‐secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity Article Snippet: To generate CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc, and CD3ε Nb‐CD63‐NLuc‐overexpressing cells, pExo plasmids encoding CD3ε Nb‐CD63, CD3ε Nb‐mouse CD63, CD63‐NLuc or CD3ε Nb‐CD63‐NLuc chimeric protein were transfected into HEK‐293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain Article Title: CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE-Secreting CAR-Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity. Article Snippet: CD3 εNb-CD63, CD3 εNb-Mouse CD63, CD63-NLuc, CD3 εNb-CD63-NLuc, HLA-G Knockdown, HLA-G KO, PD-L1 KO, and HLA-G/PD-L1 DKO To generate CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc, and CD3 ε Nb-CD63-NLuc-overexpressing cells, pExo plasmids encoding CD3 ε Nb-CD63, CD3 ε Nb-mouse CD63, CD63-NLuc or CD3 ε Nb-CD63-NLuc chimeric protein were transfected into HEK-293T or NIH/3T3 cells using Lipofectamine 3000 (L3000015, Invitrogen). .. To obtain |